Loading
Latest filing published 28 May 2026 for 하림지주.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
한국바이오텍 appears in our data through filings on 하림지주 shares, published by DART (FSS). The record holds 8 filings, for trades running from 26 November 2025 to 28 May 2026.
On the market, this insider has only ever bought: 8 purchases, €4.0M in total. The amount is not disclosed for 6 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 5 purchases and no sales.
On 28 May 2026 came the latest disclosure, an open-market purchase in 하림지주. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations